Work

Supplementary Tables 1-3, Figure Legends from A Randomized Phase II Trial of Sipuleucel-T with Concurrent versus Sequential Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Tables 1-3, Figure Legends. ST1. Median cumulative product parameters, all randomized patients; ST2. Summary of maximal percent decrease from baseline in serum PSA; ST3: Most common AEs occurring within 1 day of infusion in >5% of patients.

DOI: 10.1158/1078-0432.22456532.v1

Authors: Eric J. Small, Raymond S. Lance, Thomas A. Gardner, Lawrence I. Karsh, Lawrence Fong, Candice McCoy, Todd DeVries, Nadeem A. Sheikh, Debraj GuhaThakurta, Nancy Chang, Charles H. Redfern, Neal D. Shore

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361911583

Cites:

Cited by:

Related to: 10